trial

Treatment of Childhood Onset Psychiatric Disorders With Intravenous Immunoglobulin (IVIg)

NCTId NCT00001768
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 3 · Completed
Enrollment 10
Sponsored by National Institute of Mental Health (NIMH)
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 3
Status
Completed
Enrollment
10
Study type
Interventional
Allocation
—
Model
—
Masking
—
Start
1997-10
Primary completion
—
Eligibility
ALL

Interventions & indications

Drugs
Intravenous immunoglobulin

Sponsors

National Institute of Mental Health (NIMH)Lead Sponsor

Sites

1 total
Bethesda, United States

Facts & assertions

3 sourced
Enrollment
10
Phase
PHASE3
Status
COMPLETED
relationships
The graph out of here
drug
Intravenous immunoglobulin
drug
lead_sponsor
National Institute of Mental Health (NIMH)
company
indication
Autoimmune Diseases
indication
Autoimmune Diseases
indication
Schizophrenia
indication